Torezolid

Torezolid
	File:Torezolid.svg
Systematic (IUPAC) name
	(5R)-3-{3-fluoro-4-[6-(2-methyl-2H-tetrazol-5-yl)pyridin-3-yl]phenyl}-5-(hydroxymethyl)-1,3-oxazolidin-2-one
Legal status
Legal status	Investigational;
Identifiers
CAS Number	856866-72-3
ATC code	none
ChemSpider	9409096
Chemical data
Formula	C17H15FN6O3
Molar mass	370.338 g/mol[[Script error: No such module "String".]]
	Script error: No such module "collapsible list".

Script error: No such module "TemplatePar".Expression error: Unexpected < operator.

Torezolid (also known as TR-701) is an oxazolidinone drug in phase-II clinical trials for complicated skin and skin-structure infections (cSSSI), including those caused by Methicillin-resistant Staphylococcus aureus (MRSA).^[1]

The prodrug is called "TR-701", while the active ingredient is called "TR-700".^[2]^[3]

References

Cite error: Invalid <references> tag; parameter "group" is allowed only.

Use <references />, or <references group="..." />

50px	This systemic antibacterial-related article is a stub. You can help ssf by expanding it. v d e